[A seroprevalence study of the hepatitis C virus among multiply transfused patients].
A study was conducted on 61 polytransfused patients, 24 patients submitted to long lasting parenteral treatments, 116 blood donors and 132 controls. Immuno-enzymatic tests were used for detection of antibodies against hepatitis C virus (HCV). They were found in 56 (91.8%) out of the 61 polytransfused patients, in 5 (4.3%) of the donors, in 5 (20.8%) of the patients with multiple treatments and in 5 (3.7%) controls. The VHB markers were detected at variable rates in all investigated groups. The high rate of seropositivity indicates that hepatitis C is becoming an important public health problem in Romania.
Antipa
C
C
Institut de Virologie Stefan S. Nicolau, Bucarest, Roumanie.
Popescu
A
A
Teleguţă
M
M
Ruţă
S
S
Cernescu
C
C
Târdei
G
G
Copelovici
Y
Y
Stoian
M
M
Tivgă
N
N
Hoinărescu
M
M
D000328:Adult; D001782:Blood Donors / Q000706:statistics & numerical data; D001803:Blood Transfusion / Q000706:statistics & numerical data*; D002648:Child; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D015995:Prevalence; D012307:Risk Factors; D012383:Romania / Q000453:epidemiology; D016036:Seroepidemiologic Studies; D017086:beta-Thalassemia / Q000276:immunology / Q000628:therapy
D006508:Hepatitis Antibodies
Etudes sur la séroprévalence du virus de l'hépatite C chez les polytransfusés.